Markets Pharma innovia

The entrapment of biological materials (cells, peptides, proteins, viruses, micro-organisms…) in microparticles or bioencapsulation is widespread, both for the implementation of efficient bioconversion processes and for the protection and/or the effective delivery of sensitive compounds.

Immobilisation of micro-organisms or enzymes in bioprocesses offers numerous advantages, including a continuous production (enhanced productivity, a reduction of the operational costs) and an implementation of complex systems (e.g. multi-step enzymatic synthesis).

Regarding sensitive biological compounds, encapsulation allows not only stabilization during utilization, but also an effective transfer to the target, thus contributing to the development of new therapies and new forms of drug administration in human and animal health (vectorization of active principles).